Clínica Baviera, S.A. (FRA:D9Z)

Market Cap	929.07M +50.1%
Revenue (ttm)	304.91M +14.7%
Net Income	42.06M +4.6%
EPS	2.63 +4.5%
Shares Out	n/a
PE Ratio	22.09
Forward PE	n/a
Dividend	1.27 (2.14%)
Ex-Dividend Date	Jun 10, 2026

Volume	n/a
Open	57.40
Previous Close	58.20
Day's Range	57.40 - 57.40
52-Week Range	37.80 - 59.40
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 2, 2026

About Clínica Baviera

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, and intraocular lenses treatments. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and chang...

• Industry: Health Services
• Founded: 1992
• Employees: 1,592
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: D9Z

Financial Performance

In 2025, Clínica Baviera's revenue was 304.91 million, an increase of 14.75% compared to the previous year's 265.72 million. Earnings were 42.06 million, an increase of 4.62%.